Targets — browse / sort / filter (view)
Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target
- id
- UniProt accession (human). Links to uniprot.org.
- gene_symbol
- Gene symbol (e.g. ITGB3).
- protein_name
- Protein name (UniProt).
- tier
- Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
- has_structure
- 1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
- evidence_priority
- DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
- has_activation_state_pdb_pair
- 1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
- in_cev_map
- Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
- has_known_aptamer
- 1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
- opentargets_top_disease_score
- Open Targets association score (0-1).
- aptamer_count_pubmed
- Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
- aptamer_pmids
- The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
- surface_class
- PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.
102 rows where has_cryoEM = 1, has_known_aptamer = 1 and tier = "Tier 1.5" sorted by evidence_priority descending
This data as json, CSV (advanced)
Suggested facets: pdb_count_total, aptamer_count_pubmed
surface_class 4
- B_cargo 41
- A_surface 32
- A_assoc 21
- A2_pm_peripheral 8
tier 1
- Tier 1.5 · 102 ✖
has_structure 1
- 1 102
has_known_aptamer 1
- 1 · 102 ✖
has_cryoEM 1
- 1 · 102 ✖
has_activation_state_pdb_pair 1
- 0 102
| id | gene_symbol | protein_name | tier | evidence_priority ▲ | has_structure | surface_class | pdb_count_total | alphafold_mean_pLDDT | has_cryoEM | has_activation_state_pdb_pair | activation_state_pdb_active | activation_state_pdb_inactive | has_known_aptamer | aptamer_count_pubmed | aptamer_pmids | in_cev_map | opentargets_top_disease_name | opentargets_top_disease_score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P21359 | NF1 | Neurofibromin | Tier 1.5 | 0.965 | 1 | A_surface | 26 | 87.19 | 1 | 0 | 1 | 2 | 32980430, 22617876 | 1 | neurofibromatosis type 1 | 0.8844735398780649 | ||
| P16234 | PDGFRA | Platelet-derived growth factor receptor alpha | Tier 1.5 | 0.945 | 1 | A_surface | 14 | 72.69 | 1 | 0 | 1 | 4 | 33334063, 32127469, 28010895, 30594071 | 1 | gastrointestinal stromal tumor | 0.8167494524079806 | ||
| P15529 | CD46 | Membrane cofactor protein | Tier 1.5 | 0.934 | 1 | A_surface | 7 | 82.12 | 1 | 0 | 1 | 9 | 35114109, 34248841, 31761039, 31077760, 27734375, 19915929, 17046833, 11084032 | 1 | atypical hemolytic-uremic syndrome with MCP/CD46 anomaly | 0.7798469882597787 | ||
| P25445 | FAS | Tumor necrosis factor receptor superfamily member 6 | Tier 1.5 | 0.921 | 1 | A_surface | 7 | 77.88 | 1 | 0 | 1 | 17 | 40784034, 39897575, 37458448, 36908619, 35402075, 32270033, 31436946, 30594071, 30417194, 30339905, 26318819, 23980164, 23511245, 18997060, 18956014, 16729304, 16581027 | 1 | autoimmune lymphoproliferative syndrome type 1 | 0.7377210386590284 | ||
| P02786 | TFRC | Transferrin receptor protein 1 | Tier 1.5 | 0.887 | 1 | A_surface | 22 | 86.69 | 1 | 0 | 1 | 3 | 39831311, 29046922, 32527800 | 1 | TFRC-related combined immunodeficiency | 0.623449899069336 | ||
| P07225 | PROS1 | Vitamin K-dependent protein S | Tier 1.5 | 0.847 | 1 | A_assoc | 3 | 82.94 | 1 | 0 | 1 | 2 | 36859809, 33674695 | 1 | thrombophilia due to protein S deficiency, autosomal dominant | 0.8240418292042652 | ||
| Q92633 | LPAR1 | Lysophosphatidic acid receptor 1 | Tier 1.5 | 0.843 | 1 | A_surface | 16 | 83.62 | 1 | 0 | 1 | 1 | 32065590 | 1 | Epiretinal membrane | 0.4757255248053499 | ||
| P39060 | COL18A1 | Collagen alpha-1(XVIII) chain | Tier 1.5 | 0.836 | 1 | A_assoc | 9 | 50.62 | 1 | 0 | 1 | 2 | 36707842, 23679916 | 1 | Knobloch syndrome 1 | 0.7867122552672962 | ||
| P02748 | C9 | Complement component C9 | Tier 1.5 | 0.829 | 1 | A_assoc | 9 | 78.75 | 1 | 0 | 1 | 10 | 41636061, 40411682, 36428893, 36290981, 35247355, 28794177, 27836219, 22678933, 19261617, 15687383 | 1 | Immunodeficiency due to a late component of complements deficiency | 0.761965409699055 | ||
| P31785 | IL2RG | Cytokine receptor common subunit gamma | Tier 1.5 | 0.804 | 1 | A_surface | 14 | 75.5 | 1 | 0 | 1 | 2 | 30800133, 33869115 | 0 | gamma chain deficiency | 0.8469997000418428 | ||
| Q5ZPR3 | CD276 | CD276 antigen | Tier 1.5 | 0.804 | 1 | A_surface | 3 | 83.31 | 1 | 0 | 1 | 1 | 38866941 | 1 | response to statin | 0.3471917147958521 | ||
| P08100 | RHO | Rhodopsin | Tier 1.5 | 0.804 | 1 | A_surface | 4 | 88.75 | 1 | 0 | 1 | 45 | 41963275, 41924874, 41636061, 40808302, 40642289, 40330320, 40045571, 39863313, 39788632, 38070612, 37191882, 36705086, 36696850, 36095194, 36049339, 35622174, 34709779, 34471566, 32696702, 32479610, 32319623, 32119944, 31737572, 31588238, 31535128, 29570714, 29281176, 28648779, 27893356, 25645980, 23757206, 23701883, 25033804, 22689339, 22302221, 22121695, 19766091, 19389625, 16419035, 12123800, 8743323, 7678562, 19188685, 18230760 | 0 | retinitis pigmentosa | 0.8481942240861982 | ||
| O95342 | ABCB11 | Bile salt export pump | Tier 1.5 | 0.801 | 1 | A_surface | 8 | 83.12 | 1 | 0 | 1 | 1 | 36313979 | 0 | progressive familial intrahepatic cholestasis type 2 | 0.8372060401943777 | ||
| P08648 | ITGA5 | Integrin alpha-5 | Tier 1.5 | 0.785 | 1 | A_surface | 14 | 85.25 | 1 | 0 | 1 | 2 | 32174798, 38258032 | 1 | skin disease | 0.28465651599598124 | ||
| P51654 | GPC3 | Glypican-3 | Tier 1.5 | 0.779 | 1 | A_surface | 4 | 75.06 | 1 | 0 | 1 | 65 | 42083729, 41790019, 41653459, 41045695, 40825648, 40722645, 39998646, 39874791, 39608318, 39427046, 38910291, 38787447, 38621313, 38368644, 37665421, 36903516, 36457288, 36317566, 36072763, 35788872, 35699181, 35477501, 35051745, 34974867, 34306031, 33254049, 33080969, 32356075, 30347351, 30122918, 29675356, 29605994, 29277631, 27601357, 28263753 | 0 | Simpson-Golabi-Behmel syndrome type 1 | 0.762708583613362 | ||
| Q9ULC3 | RAB23 | Ras-related protein Rab-23 | Tier 1.5 | 0.776 | 1 | A2_pm_peripheral | 6 | 79.56 | 1 | 0 | 1 | 1 | 23618401 | 1 | RAB23-related Carpenter syndrome | 0.7879955689930709 | ||
| P20023 | CR2 | Complement receptor type 2 | Tier 1.5 | 0.776 | 1 | A_surface | 9 | 74.94 | 1 | 0 | 1 | 1 | 33235290 | 0 | immunodeficiency, common variable, 7 | 0.7543125403898414 | ||
| Q99988 | GDF15 | Growth/differentiation factor 15 | Tier 1.5 | 0.775 | 1 | A_assoc | 4 | 75.69 | 1 | 0 | 1 | 29 | 41924874, 41862097, 38879214, 38477735, 37982669, 36927042, 36638554, 36508319, 36333824, 35762561, 33334063, 32527800, 31988066, 29992704, 39884764, 38497478, 38296402, 37162508, 32739349, 30335547 | 1 | hyperemesis gravidarum | 0.5821658682742563 | ||
| P08887 | IL6R | Interleukin-6 receptor subunit alpha | Tier 1.5 | 0.768 | 1 | A_surface | 10 | 77.88 | 1 | 0 | 1 | 18 | 40853309, 38152968, 37034659, 36579647, 35890412, 33590853, 33340765, 32515246, 29211023, 28929152, 26552813, 26383776, 24481022, 24440854, 23235494, 22503683, 22258147, 22094809 | 0 | rheumatoid arthritis | 0.7269057706798291 | ||
| P10646 | TFPI | Tissue factor pathway inhibitor | Tier 1.5 | 0.768 | 1 | A_assoc | 9 | 73.62 | 1 | 0 | 1 | 28 | 32366845, 32224381, 30994257, 30302740, 27563744, 27196067, 24263002, 23528042, 22951415, 22658294, 22632032, 22239993, 21696535, 21389323, 8578509, 25521966, 24319161 | 1 | hemophilia A | 0.5591056672248635 | ||
| Q00975 | CACNA1B | Voltage-dependent N-type calcium channel subunit alpha-1B | Tier 1.5 | 0.767 | 1 | A_surface | 7 | 59.91 | 1 | 0 | 1 | 2 | 31118475, 25782368 | 0 | Seizure | 0.7217241968702018 | ||
| P02771 | AFP | Alpha-fetoprotein | Tier 1.5 | 0.765 | 1 | A_assoc | 5 | 88.94 | 1 | 0 | 1 | 195 | 41849903, 41732103, 41688234, 41327249, 41051792, 40839965, 40750207, 40684729, 40578247, 40383027, 40381048, 40347636, 40262341, 40216053, 39982565, 39942588, 39890683, 39771616, 39479488, 39383727, 39305942, 39167423, 39140150, 39082193, 39067928, 39007743, 38904836, 38852341, 38356334, 37836778, 37709445, 37606762, 37366993, 37303825, 37295202, 37284243, 37228865, 37104032, 36989661, 36979562, 36842207, 36693188, 36512161, 36389169, 36290918, 36240195, 36130652, 35969067, 35793076, 35747812, 41637558, 41575587, 41123957, 41103270, 40349714, 40286895, 38899396, 37325361 | 1 | Congenital deficiency in alpha-fetoprotein | 0.5500580170557311 | ||
| P05165 | PCCA | Propionyl-CoA carboxylase alpha chain, mitochondrial | Tier 1.5 | 0.756 | 1 | B_cargo | 25 | 87.44 | 1 | 0 | 1 | 1 | 36578103 | 1 | propionic acidemia | 0.8530542602972598 | ||
| P15391 | CD19 | B-lymphocyte antigen CD19 | Tier 1.5 | 0.755 | 1 | A_surface | 4 | 62.22 | 1 | 0 | 1 | 13 | 41079126, 40652441, 38661725, 38148412, 36095289, 35829681, 34680368, 34364920, 32401486, 31912987, 29928472, 21127492 | 0 | immunodeficiency, common variable, 3 | 0.6821072538733047 | ||
| P26440 | IVD | Isovaleryl-CoA dehydrogenase, mitochondrial | Tier 1.5 | 0.754 | 1 | B_cargo | 5 | 93.38 | 1 | 0 | 1 | 2 | 41230502, 26946282 | 1 | isovaleric acidemia | 0.8480603595890895 | ||
| P55157 | MTTP | Microsomal triglyceride transfer protein large subunit | Tier 1.5 | 0.748 | 1 | B_cargo | 2 | 86.56 | 1 | 0 | 1 | 1 | 23770039 | 1 | abetalipoproteinemia | 0.8281089516017405 | ||
| Q96RJ3 | TNFRSF13C | Tumor necrosis factor receptor superfamily member 13C | Tier 1.5 | 0.748 | 1 | A_surface | 8 | 63.03 | 1 | 0 | 1 | 1 | 23470998 | 0 | immunodeficiency, common variable, 4 | 0.660711678987284 | ||
| Q53H12 | AGK | Acylglycerol kinase, mitochondrial | Tier 1.5 | 0.747 | 1 | B_cargo | 1 | 87.0 | 1 | 0 | 1 | 1 | 35763566 | 1 | Sengers syndrome | 0.8231275438888749 | ||
| P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | Tier 1.5 | 0.744 | 1 | B_cargo | 10 | 87.25 | 1 | 0 | 1 | 5 | 41290466, 38569854, 31879964, 31702021, 21433395 | 1 | Chronic mucocutaneous candidosis | 0.8147374964880533 | ||
| P43007 | SLC1A4 | Neutral amino acid transporter A | Tier 1.5 | 0.741 | 1 | B_cargo | 1 | 80.56 | 1 | 0 | 1 | 6 | 36219068, 31989939, 27571928, 26811678, 19046328, 16139842 | 1 | spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome | 0.8025684205131692 | ||
| Q8NER1 | TRPV1 | Transient receptor potential cation channel subfamily V member 1 | Tier 1.5 | 0.738 | 1 | A_surface | 8 | 71.94 | 1 | 0 | 1 | 2 | 40855286, 28604222 | 0 | migraine disorder | 0.6269329225883602 | ||
| P42658 | DPP6 | A-type potassium channel modulatory protein DPP6 | Tier 1.5 | 0.737 | 1 | A_surface | 8 | 86.69 | 1 | 0 | 1 | 1 | 41313574 | 0 | Autosomal dominant microcephaly | 0.6225938492787458 | ||
| P98155 | VLDLR | Very low-density lipoprotein receptor | Tier 1.5 | 0.737 | 1 | B_cargo | 27 | 75.69 | 1 | 0 | 1 | 1 | 19188685 | 1 | Dysequilibrium syndrome | 0.790164037509625 | ||
| P01876 | IGHA1 | Immunoglobulin heavy constant alpha 1 | Tier 1.5 | 0.736 | 1 | A_surface | 14 | 81.88 | 1 | 0 | 1 | 2 | 37325361 | 1 | IGA glomerulonephritis | 0.12053726815801102 | ||
| Q15813 | TBCE | Tubulin-specific chaperone E | Tier 1.5 | 0.732 | 1 | B_cargo | 6 | 89.19 | 1 | 0 | 1 | 1 | 34448574 | 1 | hypoparathyroidism-retardation-dysmorphism syndrome | 0.7744447925917005 | ||
| Q13043 | STK4 | Serine/threonine-protein kinase 4 | Tier 1.5 | 0.728 | 1 | B_cargo | 16 | 75.94 | 1 | 0 | 1 | 1 | 31707227 | 1 | combined immunodeficiency due to STK4 deficiency | 0.7613382040802787 | ||
| P01877 | IGHA2 | Immunoglobulin heavy constant alpha 2 | Tier 1.5 | 0.726 | 1 | A_surface | 4 | 83.0 | 1 | 0 | 1 | 2 | 37325361 | 1 | Chronic mucocutaneous candidosis | 0.08794784007807564 | ||
| P07237 | P4HB | Protein disulfide-isomerase | Tier 1.5 | 0.723 | 1 | B_cargo | 14 | 88.5 | 1 | 0 | 1 | 2 | 31625090, 28952381 | 1 | Cole-Carpenter syndrome | 0.7447295842045853 | ||
| P18627 | LAG3 | Lymphocyte activation gene 3 protein | Tier 1.5 | 0.72 | 1 | A_surface | 6 | 78.38 | 1 | 0 | 1 | 6 | 40761795, 38158454, 36603108, 28934318 | 0 | melanoma | 0.5672649687930189 | ||
| P32121 | ARRB2 | Beta-arrestin-2 | Tier 1.5 | 0.719 | 1 | A2_pm_peripheral | 1 | 83.81 | 1 | 0 | 1 | 4 | 24736311, 40652239, 29054528 | 1 | cancer | 0.5962458729823639 | ||
| P24593 | IGFBP5 | Insulin-like growth factor-binding protein 5 | Tier 1.5 | 0.711 | 1 | A_assoc | 3 | 76.06 | 1 | 0 | 1 | 4 | 39317671, 31930684 | 1 | hypothyroidism | 0.3702458751451027 | ||
| Q13158 | FADD | FAS-associated death domain protein | Tier 1.5 | 0.708 | 1 | B_cargo | 18 | 72.12 | 1 | 0 | 1 | 3 | 36309655, 30594071, 26318819 | 1 | FADD-related immunodeficiency | 0.6932338529214827 | ||
| P55259 | GP2 | Pancreatic secretory granule membrane major glycoprotein GP2 | Tier 1.5 | 0.707 | 1 | A_surface | 4 | 78.62 | 1 | 0 | 1 | 3 | 36902059, 25483705, 24334484 | 0 | type 2 diabetes mellitus | 0.5235291484788168 | ||
| Q00604 | NDP | Norrin | Tier 1.5 | 0.707 | 1 | A_assoc | 11 | 83.56 | 1 | 0 | 1 | 2 | 39057719, 11352723 | 0 | Norrie disease | 0.8566451682188412 | ||
| O43866 | CD5L | CD5 antigen-like | Tier 1.5 | 0.706 | 1 | A_assoc | 4 | 85.88 | 1 | 0 | 1 | 3 | 40215752, 37100807 | 1 | functional neutrophil defect | 0.3529395470693119 | ||
| P10145 | CXCL8 | Interleukin-8 | Tier 1.5 | 0.706 | 1 | A_assoc | 21 | 88.06 | 1 | 0 | 1 | 15 | 39564692, 35821507, 31985806, 29268188, 41866852, 37732574, 37016361, 36037714, 35197258, 34884636, 25998051, 24129312 | 1 | coronary artery disease | 0.35357870191996843 | ||
| P25106 | ACKR3 | Atypical chemokine receptor 3 | Tier 1.5 | 0.7 | 1 | A_surface | 14 | 82.44 | 1 | 0 | 1 | 2 | 40401615, 28670693 | 0 | oculomotor-abducens synkinesis | 0.49893280382434735 | ||
| P80162 | CXCL6 | C-X-C motif chemokine 6 | Tier 1.5 | 0.699 | 1 | A_assoc | 2 | 81.0 | 1 | 0 | 1 | 3 | 40008515, 36649818, 32628701 | 1 | neurodegenerative disease | 0.3309117033683961 | ||
| P31948 | STIP1 | Stress-induced-phosphoprotein 1 | Tier 1.5 | 0.689 | 1 | A2_pm_peripheral | 8 | 89.75 | 1 | 0 | 1 | 7 | 41406518, 38012811, 34831332, 32614006, 27681499, 24654750, 24013070 | 1 | neurodegenerative disease | 0.4967711525222825 | ||
| P21980 | TGM2 | Protein-glutamine gamma-glutamyltransferase 2 | Tier 1.5 | 0.688 | 1 | A2_pm_peripheral | 17 | 92.88 | 1 | 0 | 1 | 1 | 35980938 | 1 | neurodegenerative disease | 0.49455272812698803 |
Advanced export
JSON shape: default, array, newline-delimited
CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
-- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
-- Transparent weights over harvested evidence: structure 0.35, disease importance
-- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
-- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
-- are predictions/detections, NOT measured EV-surface exposure.
ROUND(
0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
+ 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
+ 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
+ 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
, 3) AS evidence_priority,
(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
sc.surface_class,
f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;